The dilemma of carboplatin-associated hypersensitivity reactions in ovarian cancer management.
Maurie
M
Markman
D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D016190:Carboplatin / Q000008:administration & dosage / Q000009:adverse effects*; D015897:Comorbidity; D000075202:Contraindications; D004342:Drug Hypersensitivity / Q000517:prevention & control; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D012720:Severity of Illness Index
D000970:Antineoplastic Agents; D016190:Carboplatin